Effectiveness of electroconvulsive therapy in community settings
- PMID: 14744473
- DOI: 10.1016/j.biopsych.2003.09.015
Effectiveness of electroconvulsive therapy in community settings
Abstract
Background: Clinical trials indicate that electroconvulsive therapy (ECT) is the most effective treatment for major depression, but its effectiveness in community settings has not been examined.
Methods: In a prospective, naturalistic study involving 347 patients at seven hospitals, clinical outcomes immediately after ECT and over a 24-week follow-up period were examined in relation to patient characteristics and treatment variables.
Results: The sites differed markedly in patient features and ECT administration but did not differ in clinical outcomes. In contrast to the 70%-90% remission rates expected with ECT, remission rates, depending on criteria, were 30.3%-46.7%. Longer episode duration, comorbid personality disorder, and schizoaffective disorder were associated with poorer outcome. Among remitters, the relapse rate during follow-up was 64.3%. Relapse was more frequent in patients with psychotic depression or comorbid Axis I or Axis II disorders. Only 23.4% of ECT nonremitters had sustained remission during follow-up.
Conclusions: The remission rate with ECT in community settings is substantially less than that in clinical trials. Providers frequently end the ECT course with the view that patients have benefited fully, yet formal assessment shows significant residual symptoms. Patients who do not remit with ECT have a poor prognosis; this underscores the need to achieve maximal improvement with this modality.
Comment in
-
Low efficacy electroconvulsive therapy in community settings.Biol Psychiatry. 2004 Dec 1;56(11):905; author reply 905-6. doi: 10.1016/j.biopsych.2004.08.011. Biol Psychiatry. 2004. PMID: 15576072 No abstract available.
Similar articles
-
Early Complete Remitters After Electroconvulsive Therapy: Profile and Prognosis.J ECT. 2016 Jun;32(2):82-7. doi: 10.1097/YCT.0000000000000298. J ECT. 2016. PMID: 26796500 Clinical Trial.
-
Long-term treatment strategies in major depression: a 2-year prospective naturalistic follow-up after successful electroconvulsive therapy.J ECT. 2012 Jun;28(2):92-7. doi: 10.1097/YCT.0b013e31823e2705. J ECT. 2012. PMID: 22531201
-
ECT non-remitters: prognosis and treatment after 12 unilateral electroconvulsive therapy sessions for major depression.J Affect Disord. 2020 Jul 1;272:501-507. doi: 10.1016/j.jad.2020.03.134. Epub 2020 Apr 29. J Affect Disord. 2020. PMID: 32553394 Clinical Trial.
-
Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis.Br J Psychiatry. 2018 Feb;212(2):71-80. doi: 10.1192/bjp.2017.28. Br J Psychiatry. 2018. PMID: 29436330 Review.
-
Electroconvulsive therapy for older adult patients with major depressive disorder: a systematic review of randomized controlled trials.Psychogeriatrics. 2018 Nov;18(6):468-475. doi: 10.1111/psyg.12359. Epub 2018 Aug 2. Psychogeriatrics. 2018. PMID: 30073725 Review.
Cited by
-
Effectiveness of Emotional Memory Reactivation vs Control Memory Reactivation Before Electroconvulsive Therapy in Adult Patients With Depressive Disorder: A Randomized Clinical Trial.JAMA Netw Open. 2020 Aug 3;3(8):e2012389. doi: 10.1001/jamanetworkopen.2020.12389. JAMA Netw Open. 2020. PMID: 32749468 Free PMC article. Clinical Trial.
-
Promoting recovery of sexual functioning after radical prostatectomy with group-based stress management: the role of interpersonal sensitivity.J Psychosom Res. 2008 May;64(5):527-36. doi: 10.1016/j.jpsychores.2008.01.004. J Psychosom Res. 2008. PMID: 18440406 Free PMC article.
-
The clinical profile and outcome of patients receiving continuation electroconvulsive therapy (C-ECT): A retrospective study.Indian J Psychiatry. 2023 Jun;65(6):647-654. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_169_23. Epub 2023 Jun 19. Indian J Psychiatry. 2023. PMID: 37485402 Free PMC article.
-
Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders--a population based study.BMC Psychiatry. 2012 Aug 17;12:115. doi: 10.1186/1471-244X-12-115. BMC Psychiatry. 2012. PMID: 22900754 Free PMC article.
-
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy.Pharmacopsychiatry. 2023 Mar;56(2):64-72. doi: 10.1055/a-2034-6536. Epub 2023 Mar 21. Pharmacopsychiatry. 2023. PMID: 36944329 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical